Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Therapeutic Effect and Molecular Mechanism of the Ultra-Low Molecule Compound K on Multiple Myeloma

Myung Geun Shin, Hye Ran Kim, Young Eun Lee, Ha Jin Lim, Jong Hee Shin

Blood (2024) 144 (Supplement 1): 7473.

https://doi.org/10.1182/blood-2024-201279

Published: 2024

Journal Articles

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Yu Been Oh, Young Eun Lee, Ha Jin Lim, Yong Jun Kwon, Yong Jun Choi, Joo Heon Park, Hyun-Jung Choi, Hyun-Woo Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Myung Geun Shin

Blood (2024) 144 (Supplement 1): 6668.

https://doi.org/10.1182/blood-2024-202880

Published: 2024

Journal Articles

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

Young Eun Lee, Hye Ran Kim, Ha Jin Lim, Yong Jun Choi, Joo Heon Park, Hyun-Woo Choi, Hyun-Jung Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Chang Soo Park, Myung Geun Shin

Blood (2023) 142 (Supplement 1): 6034.

https://doi.org/10.1182/blood-2023-180448

Published: 2023

Journal Articles

Efficacy Evaluation of a Tetracyclic Triterpene Compound Targeting Multiple Apoptosis Proteins for the Development of a Multiple Myeloma Treatment

Hye Ran Kim, Young Eun Lee, Ha Jin Lim, Yong Jun Choi, Joo Heon Park, Jong Hee Shin, Chang Soo Park, Myung Geun Shin

Blood (2023) 142 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2023-180362

Published: 2023

Journal Articles

Anti-Myeloma Effect of Compound K and Rh2 in a Multiple Myeloma Xenograft Model

Hye Ran Kim, Young Eun Lee, Jin Young Kim, Yong Jun Choi, Ju Heon Park, Jong Hee Shin, Myung-Geun Shin

Blood (2022) 140 (Supplement 1): 12469–12470.

https://doi.org/10.1182/blood-2022-156859

Published: 2022

Journal Articles

Derivative Compounds of Chromanone As Candidates for Multiple Myeloma-Targeted Anticancer Drugs

Young Eun Lee, Ju Heon Park, Ha Jin Lim, Hye Ran Kim, Jong Hee Shin, Myung-Geun Shin

Blood (2022) 140 (Supplement 1): 9947–9948.

https://doi.org/10.1182/blood-2022-156765

Published: 2022

Journal Articles

A Clinical Laboratory-Oriented Targeted RNA-Seq System Accurately and Efficiently Detected Various Fusion Gene Mutations in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia

Yong Jun Choi, Ju Heon Park, Young Eun Lee, Ha Jin Lim, Ji Hu Jeon, Hye Ran Kim, Jong Hee Shin, Myung-Geun Shin

Blood (2022) 140 (Supplement 1): 11860–11861.

https://doi.org/10.1182/blood-2022-156750

Published: 2022

Journal Articles

Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System As a Comprehensive Assay for Hematologic Malignancies

Ha Jin Lim, MD, Jun Hyung Lee, MD PhD, Ju-Hyeon Shin, MD, Seung Yeob Lee, MD PhD, Hyun-Woo Choi, MD PhD, Hyun Jung Choi, MD PhD, Seung Jung Kee, MD PhD, Jong Hee Shin, MD PhD, Myung-Geun Shin, MD PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-142264

Published: 2020

Journal Articles

RNA Sequencing Based Whole Transcriptome Analysis Detected Precisely All Fusion Transcripts in Leukemias

Myung Geun Shin, MD PhD, Jun Hyung Lee, MD, Hyun Jung Choi, MD PhD, Seung Jung Kee, MD PhD, Soo Hyun Kim, MD PhD, Jong Hee Shin, MD PhD, Soon Pal Suh, MD PhD

Blood (2018) 132 (Supplement 1): 1496.

https://doi.org/10.1182/blood-2018-99-115785

Published: 2018

Journal Articles

Expression Status of Prohibitin Gene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics

Myung Geun Shin, MD PhD, Jun Hyung Lee, MD, Hye Ran Kim, PhD, Bo Ram Na, BS, Young Eun Lee, BS, Hyun Jung Choi, MD PhD, Soo Hyun Kim, MD PhD, Jong Hee Shin, MD PhD, Soon Pal Suh, MD PhD

Blood (2018) 132 (Supplement 1): 1497.

https://doi.org/10.1182/blood-2018-99-115726

Published: 2018

Journal Articles

Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia

Jun Hyung Lee, MD MS, Hyun-Jung Choi, MD PhD, Soo-Hyun Kim, MD PhD, Jong-Hee Shin, MD PhD, Soon-Pal Suh, MD PhD, Myung-Geun Shin, MD PhD

Blood (2017) 130 (Supplement 1): 2677.

https://doi.org/10.1182/blood.V130.Suppl_1.2677.2677

Published: 2017

Journal Articles

Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia

Hye-Ran Kim, PhD, Jun Hyung Lee, MD, Min-Gu Kang, MD, Ra-Young Park, PhD, Moinul Md Hoque, B.S., Sol Jeong, B.S., Min-Seo Noh, B.S., Seok-Yong Choi, MD, PhD, Soo-Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2016) 128 (22): 1714.

https://doi.org/10.1182/blood.V128.22.1714.1714

Published: 2016

Journal Articles

No Mutations of SF3B1 , U2AF1 , and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma

Min-Gu Kang, MD, Hye-Ran Kim, PhD, Jun Hyung Lee, MD, Thashma Pemmanda Ganapathy, M.S., Seung-Hyeon Yang, B.S., Moinul Hoque, B.S., Ra-Young Park, PhD, Seung Jung Kee, MD, PhD, Soo Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2015) 126 (23): 4190.

https://doi.org/10.1182/blood.V126.23.4190.4190

Published: 2015

Journal Articles

Altered Cellular Responses As Biomarkers for Fluoranthene Exposure to the Bone Marrow-Mesenchymal Stem Cells: Implications for Stem Cell-Based in Vitro Models That Help Determine the Associated Hematotoxicity

Hwan-Young Kim, Ji-Eun Noh, Hee-Jo Baek, MD PhD, Jae-Dong Moon, MD PhD, Jong-Hee Shin, MD PhD, Soon-Pal Suh, MD PhD, Hoon Kook, MD PhD, Dong-Wook Ryang, MD PhD, Myung-Geun Shin, MD PhD

Blood (2014) 124 (21): 5976.

https://doi.org/10.1182/blood.V124.21.5976.5976

Published: 2014

Journal Articles

Development Of Novel Alkylating Chemotherapeutics, Phenyl-Chloroethyl Urea Family, Targeting Mitochondrial Prohibitin For Selective Killing Of Leukemic Cells

Hye-Ran Kim, Ph.D, Hwan-Young Kim, Trang Nguyen Thi Dai, Il-Kwon Lee, Hyeoung-Joon Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 1325.

https://doi.org/10.1182/blood.V122.21.1325.1325

Published: 2013

Journal Articles

Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome

Jae-Sook Ahn, MD, PhD, Hye-Ran Kim, PhD, Hyeoung-Joon Kim, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, PhD, Je-Jung Lee, MD, PhD, Nguyen Thi Dai Trang, Hyun-Woo Choi, MD, Min-Gu Kang, MD, Hwan-Young Kim, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 2802.

https://doi.org/10.1182/blood.V122.21.2802.2802

Published: 2013

Journal Articles

Serum Level Of Parathyroid Hormone Is Associated With Risk Factors and Clinical Outcomes In Multiple Myeloma

Min-Gu Kang, MD, Min-Joong Jang, O-jin Lee, Min-Seok Heo, Hyun-Woo Choi, MD, Hwan-Young Kim, Nguyen Thi Dai Trang, Deok-Hwan Yang, Je-Jung Lee, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, Ph.D, Dong-Wook Ryang, MD., Ph.D, Hye-Ran Kim, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 5365.

https://doi.org/10.1182/blood.V122.21.5365.5365

Published: 2013

Journal Articles

Prevalence and Clinical Impacts Of SETBP1 Mutation In East Asian Patients With MDS/MPN

Hyun-Woo Choi, MD, Hye-Ran Kim, PhD, Hwan-Young Kim, Ju-Heon Park, MD, Jae-Sook Ahn, Duck Cho, MD, PhD, Seung-Jung Kee, MD, PhD, Soo-Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 2629.

https://doi.org/10.1182/blood.V122.21.2629.2629

Published: 2013

Journal Articles

Profiling Of Polycyclic Aromatic Hydrocarbons-Induced Genotoxicity In Peripheral Blood Stem Cells and Bone Marrow Mesenchymal Stem Cells

Hwan-Young Kim, Hye-Ran Kim, PhD, Trang Nguyen Thi Dai, Hee-Jo Baek, MD, PhD, Jae-Dong Moon, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Hoon Kook, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 1221.

https://doi.org/10.1182/blood.V122.21.1221.1221

Published: 2013

Journal Articles

Protein Profiling of Hematopoietic Progenitor Cells and Leukemia Cells Identifies Novel Biomarkers Associated with Exposure of Polycyclic Aromatic Hydrocarbons

Hwan-Young Kim, Hye-Ran Kim, PhD, Stephanie J. Won, Hee-Jo Baek, MD, PhD, Jae-Dong Moon, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Hoon Kook, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2012) 120 (21): 4690.

https://doi.org/10.1182/blood.V120.21.4690.4690

Published: 2012

NARROW

Therapeutic Effect and Molecular Mechanism of the Ultra-Low Molecule Compound K on Multiple Myeloma

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

Efficacy Evaluation of a Tetracyclic Triterpene Compound Targeting Multiple Apoptosis Proteins for the Development of a Multiple Myeloma Treatment

Anti-Myeloma Effect of Compound K and Rh2 in a Multiple Myeloma Xenograft Model

Derivative Compounds of Chromanone As Candidates for Multiple Myeloma-Targeted Anticancer Drugs

A Clinical Laboratory-Oriented Targeted RNA-Seq System Accurately and Efficiently Detected Various Fusion Gene Mutations in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia

Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System As a Comprehensive Assay for Hematologic Malignancies

RNA Sequencing Based Whole Transcriptome Analysis Detected Precisely All Fusion Transcripts in Leukemias

Expression Status of Prohibitin Gene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics

Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia

Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia

No Mutations of SF3B1 , U2AF1 , and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma

Altered Cellular Responses As Biomarkers for Fluoranthene Exposure to the Bone Marrow-Mesenchymal Stem Cells: Implications for Stem Cell-Based in Vitro Models That Help Determine the Associated Hematotoxicity

Development Of Novel Alkylating Chemotherapeutics, Phenyl-Chloroethyl Urea Family, Targeting Mitochondrial Prohibitin For Selective Killing Of Leukemic Cells

Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome

Serum Level Of Parathyroid Hormone Is Associated With Risk Factors and Clinical Outcomes In Multiple Myeloma

Prevalence and Clinical Impacts Of SETBP1 Mutation In East Asian Patients With MDS/MPN

Profiling Of Polycyclic Aromatic Hydrocarbons-Induced Genotoxicity In Peripheral Blood Stem Cells and Bone Marrow Mesenchymal Stem Cells

Protein Profiling of Hematopoietic Progenitor Cells and Leukemia Cells Identifies Novel Biomarkers Associated with Exposure of Polycyclic Aromatic Hydrocarbons

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only